SlideShare une entreprise Scribd logo
1  sur  29
Télécharger pour lire hors ligne
PARAQUAT POISONING
DR BODHISATWA CHOUDHURI
MBBS, MD(Med), MRCEM(UK), MEM(GWU-USA), MRCP Acute Medicine(UK),
Dip Rheumatology(UK), FCCS, CCEBDM, Dip Echo(IAE)
Consultant & In-Charge, Emergency & Critical Care, Medicine & Rheumatology,
Parkview Super-specialty Hospital, Saltlake, Kolkata
Secretary, SEMI West Bengal Chapter
INTRODUCTION
• Paraquat is a highly toxic & widely used bipiridyl compound
• Was discovered in 1950s and found its way into agricultural use by 1962
• Primarily used for weed and grass control, but due to its highly poisonous
nature was soon categorized as a “restricted-use” herbicide
• However, as it is cheap and effective, its unregulated use in developing
countries like India has made it a commonly used pesticide
• It is exceedingly toxic to humans, and a minimal ingestion of 10–20 mL of
20% paraquat (around a mouthful) is lethal
• Concentrated solutions are known to corrode even mild steel and
aluminum
INCIDENCE
• Global problem
• Trinidad, Tobago, Samoa – reported around 63-76% suicidal deaths on
late nineties – due to Paraquat self-poisoning
• England & Wales – reported 56% deaths due to paraquat use out of
all pesticide ingestion between 1945-1989
• USA – Paraquat was responsible or greater number of deaths than
any other pesticide in 2008
• The case fatality rate in paraquat is as high as 70%
• Almost all European countries have banned paraquat due to high
mortality
PATHOPHYSIOLOGY
• Oxidative stress and Generation of free radicals:
• Redox cycling - Generates Reactive oxygen species (ROS) like – NADPH, NADH-
Ubiquinone oxidoreductase, cytochrome P450 reductase, NO synthase, xanthine
oxidase
• Further generates superoxide (O2
-) inside cell
• NO combines with superoxide to produce Peroxynitrite (ONOO-), a very strong
oxidant
• This strongly active oxygen & nitrite species is highly toxic majority of organs
• Effects of Oxidative stress:
• Lipid peroxidation
• Mitochondrial toxicity
• Oxidation of NADPH
• Activation of NF-kB
• Apoptosis
MECHANISM OF TOXICITY
• Multiple synergistic mechanisms – usually occurs simultaneously
• The principal target organ for paraquat poisoning is the lung and kidney
• Lungs: Major impact – alveolar epithelium remains the most affected part in
lungs
• Acute alveolitis, diffuse alveolar collapse, congested vessels, apoptosis,
attachment of PMLs & activated platelets to vascular endothelium
• 3 overlapping phases: acute destructive phase, proliferative phase, lung
fibrosis
• Kidney: Paraquat is actively secreted by the kidney – its accumulation in the
proximal tubular epithelial cells at higher concentrations – causes vacuolation in
the cells of the PCT – causing renal tubular necrosis
• Liver: Hepatocellular injury occurs secondary to mitochondrial damage and
endoplasmic reticulum degranulation
TOXICOKINETICS
• Rapid but incomplete absorption in gut upon ingestion
• Rapidly distributed to highly vascular organs – lung, liver, kidney,
muscle
• Within 12-24 hours, kidneys excrete majority of the absorbed
paraquat rapidly
• But in severe poisoning, renal clearance declines rapidly after few
hours – leads to slow clearance of paraquat distributed to deeper
compartments – over days to weeks
• Type II pneumocytes take up paraquat against concentration gradient
– behaves like a third ‘toxic effect’ compartment – has even slower
elimination rate than other deeper compartments
CLINICAL PRESENTATION
• Pulmonary:
• Paraquat concentration in the lung is 10–20 times greater than in the plasma
due to the energy-dependent uptake of the poison by the alveoli, which
persists despite decreasing paraquat levels in the blood
• Involvement of the lung in the form of diffuse alveolitis (over 1–3 days) and
subsequent pulmonary fibrosis is the hallmark of paraquat poisoning
• Symptoms – cough, hemoptysis, dyspnoea
• Rarely, pneumothorax, pleural effusion and pulmonary edema
• ARDS sets in after 24–48 hours of exposure
• Skin: Erythema, eruptions, ulceration of skin may occur
• Eyes: inflammation, ulceration of conjunctive, cornea, diminution of vision –
healing is slow with complete recovery
CLINICAL PRESENTATION
• GI Tract:
• Local irritation – nausea, vomiting
• Caustic – Ulceration of tongue & mouth [Paraquat tongue], sloughing of
oropharyngeal mucosa, dysphagia
• Severe – perforation of esophagus, mediastinitis, surgical emphysema,
pneumothorax, pleural effusion
• Jaundice, hepatomegaly, hepatitis, pancreatitis – pain abdomen
• Renal:
• Oliguric or non-oliguric failure – mostly due to ATN – becomes evident in 1-2
days
• Hematuria, proteinuria, glycosuria, excessive leakage of Na & urate
PARAQUAT TONGUE
Multiple erosions and superficial
ulcers over tongue covered with
yellowish necrotic debris
CLINICAL PRESENTATION
• CVS:
• Initially sinus tachycardia
• Lately, Myocarditis, VT, non-specific ST-T changes, intraventriclar
conduction defects
• Terminal – hypotension, sinus bradycardia
• Neurological: cerebral edema – ataxia, convulsion, facial paresis,
finally coma
• Endocrine: adrenal cortical necrosis
CLASSIFICATION OF SEVERITY
DIAGNOSIS & INVESTIGATIONS
• Mainstay is circumstantial history - history of exposure, evidence of paraquat exposure
and the amount of poison ingested
• ABG – respiratory/metabolic acidosis
• Routine labs: deranged based on organ involvement – regular monitoring of KFT, LFT,
Electrolytes, Lactate, CBC
• Serum Cr: Rate of increase correlates with survival – <0.034mg/dl/hr over 5 hours –
survival; >0.049mg/dl/hr over 6 hours – death
• Chest X-ray: useful in detecting early insult to the lungs (alveolitis), pulmonary fibrosis,
ARDS, and rarer complications like pneumomediastinum or pneumothorax
• ECG
• Amylase, Lipase – to rule out toxin-induced pancreatitis
SPECIFIC INVESTIGATIONS
• Plasma and urine sodium dithionate tests - simple, bedside methods to assess
systemic paraquat toxicity
• In an alkaline medium, dithionate reduces paraquat to a blue radical (if urine
paraquat concentration >1 mg/L or plasma paraquat concentration >2 mg/L)
• Darker the colour, more the concentration
• Helps in predicting prognosis in paraquat poisoning – positive test ~40%
mortality, negative test ~100% survival
• Qualitative assessment of paraquat poisoning
• Measurement of Paraquat concentration in plasma and urine - quantitative
assessment of paraquat poisoning, but not commonly available and the results
are often delayed
SEVERITY INDEX OF PARAQUAT POISONING
(SIPP SCORE)
• Best predictor of survival after self-poisoning
• SIPP Score: The time from paraquat ingestion (to intensive treatment) [in hours] x
Serum paraquat levels at admission [mg/dl]
• Score <10 – survival is likely
• Useful in planning treatment, determining the prognosis and studying the
pathology of acute paraquat poisoning
• Also effective in comparing therapeutic results at different stages of treatment
and in evaluating new therapeutic methods
• Challenges: imprecise time of exposure, paraquat assay within relevant time
frame
MANAGEMENT
• There is no accepted & effective treatment guideline for paraquat
poisoning
• Most of the treatment options are extrapolated from small,
uncontrolled animal studies
• Treatment given is either supportive care alone or combinations of
various supportive measures
• Even the best centers have an overall mortality greater than 50%
AIRWAY MANAGEMENT AND
DECONTAMINATION
• Patient is conscious with no vomiting - consider gastric lavage with activated charcoal (1–2 g/kg)
or Fuller’s earth (1–2 g/kg) - aids in gastric decontamination and prevents further absorption
• Supplemental oxygen is not advocated - as the oxygen free radical-mediated cytotoxic injury
causes rapid worsening of pulmonary alveolar infiltrates, leading to the ARDS and subsequent
pulmonary fibrosis if the patient survives the acute phase
• Corrosive poison - so early insertion of a nasogastric tube - to maintain nutrition; may be very
challenging due to severe ulcerations and friable mucosa, which may lead to complications
including perforation
• Keep NPM in the early phase
• Oral lesions can be very painful - may need anticholinergic agents such as diphenhydramine; an
anesthetic, such as viscous lidocaine; and an antacid or mucosal coating agent, such as
magnesium or aluminum hydroxide, kaolin, or sucralfate
• Antibiotics may be used for supervening infections
VENTILATION
• Development of type 2 respiratory failure may be an early predictor
of ARDS in patients - worse outcome
• Management of oxygenation and ventilation is identical to ARDS due
to any other etiology (ARDS protocol, lung protective strategy)
• Limit FiO2 to minimum to maintain PaO2 of about 60–65 mm Hg or
SpO2 88–90%
• Usually patients who get intubated for respiratory failure have a
stormy course and deteriorate rapidly in few hours to days
• Experimental: addition of NO (25 ppm) to inhaled gas
HAEMODIALYSIS AND HAEMOFILTRATION
• Initial management includes rehydration with IV fluids
• Target UOP 1-2 ml/kg body wt/hr
• In all cases of paraquat poisoning (significant ingestion),
hemoperfusion is the first and the earliest modality of treatment of
removal of paraquat
• Clinical benefit only when initiated within 2 hours post-ingestion
• Initiating HD/HP 2-4 hours after ingestion can reduce plasma
paraquat concentration, but those taken up by lungs gets reduced
negligibly, thus unlikely to change overall outcome
• Proposed a treatment strategy -
• to use up to seven hemoperfusion sessions (6–8 hours duration)
• to be started within 4 hours of ingestion
• maintained until plasma paraquat levels would be <0.2 mg/L
• Prospective, controlled interventional study over 4 years
• Recruited patients admitted to Shanghai Tenth People's Hospital
within 48 hours after paraquat ingestion
• Concluded that treatment with combined continuous venovenous
hemofiltration and hemoperfusion significantly improved 90-day
survival rates in paraquat poisoning
IMMUNOSUPPRESSANTS
• Interferes with the acute inflammatory response causing alveolitis
and lung fibrosis
• Options: Cyclophosphamide, Methylprednisolone pulse,
Dexamethasone
• Dexamethasone has shown to cause significantly reduced paraquat
accumulation in lung tissues
• No mode of treatment is shown to be effective in preventing lung
injury or fibrosis once it is established
• But some degree of benefit is seen when given early in course of
treatment
• Target: severe paraquat-poisoned patients with >50% to <90% predictive
mortality
• Initial pulse therapy with methylprednisolone (1 g/day for 3 days) and
cyclophosphamide (15 mg/kg/day for 2 days), followed by dexamethasone 20
mg/day until Pao2 was >11.5 kPa (80 mm Hg)
• Repeated pulse therapy with methylprednisolone (1 g/day for 3 days) and
cyclophosphamide (15 mg/kg/day for 1 day), if Pao2 was <8.64 kPa (60 mm Hg)
• The mortality rate (85.7%) of the control group was higher than that of the study
group (31.3%; p = .0272)
ANTIOXIDANTS
• Tried to overcome circulatory shock due to reactive oxygen species, causing lactic
acidosis, lung & renal injury
• N-Acetyl cysteine: found to increase the level of glutathione (antioxidant) by
suppressing the superoxide production - 150 mg/kg over 3 hours; 300 mg/kg over
24 hours for up to 3 weeks
• Vitamin C: can donate electrons to free radicals and hence neutralize them
• High doses of vitamin C (300 mg twice daily orally) reduced mortality in a case
series of 10 patients
• Vitamin E: acts by membrane stabilization, oxygen free radical scavenging,
inhibiting activation of NF-kB
• Deferoxamine: chelate iron that acts as a catalyst in the production of hydroxyl
radicals (100 mg/kg over 24 hours)
• Salicylic Acid: Anti-inflammatory, anti-oxidant, hydroxyl radical scavenger, inhibits
activation of NF-kB & lipid peroxidation
NOVEL THERAPIES
• Edaravone: free radical-scavenging antioxidant, which also has
antiapoptotic, necrotic, and anti-inflammatory effects – beneficial for
protecting the kidneys and liver from paraquat poisoning, but did not
reduce pulmonary fibrosis , only delayed it
• Anti-C5a Antibodies: anti-inflammatory
• Lung irradiation: proposed for inhibiting fibroblastic proliferation
• Lung transplantation
• ECMO: as a bridge to sequential bilateral lung transplantation
CONCLUSION
• Paraquat poisoning is a leading cause of death from pesticide poisoning with mortality of
>70%
• The literature on paraquat poisoning in India is sparse and the evidence on management
is vague and lacks proven survival benefit
• Though India is among the highest users of this herbicide worldwide, we are yet to equip
ourselves with evidence-based treatment to successfully manage paraquat poisoning
• Lungs are affected the most – as they take up the poison against a concentration gradient
• No proven treatment or antidote
• Oxygen supplementation may further worsen oxidative stress, so should be avoided in
mild to moderate hypoxia
• Extracorporeal elimination by HD/HP should be considered early – within 1-2 hours post-
ingestion
NATIONAL POISONS INFORMATION CENTRE
(NPIC)
Call 24 hours a day, 7 days a week, 365 days a year.
Toll Free No. - 1800 116 117
Tel No.- 26589391 , 26593677
Paraquat
THANK YOU
Any questions??
Contact: 9830636315
E-mail: bodhi.doc@gmail.com

Contenu connexe

Tendances

Celphos poisoning
Celphos poisoningCelphos poisoning
Celphos poisoningmohmeet
 
Resp failure talk 9 10 bipap and hfnc emphasis
Resp failure talk 9 10  bipap and hfnc emphasisResp failure talk 9 10  bipap and hfnc emphasis
Resp failure talk 9 10 bipap and hfnc emphasisStevenP302
 
100 most popular anesthesiologists of india 2018
100 most  popular anesthesiologists of india 2018100 most  popular anesthesiologists of india 2018
100 most popular anesthesiologists of india 2018dr tushar chokshi
 
Rodenticide Poisoning + Rat Killer paste poisoning management
Rodenticide Poisoning + Rat Killer paste poisoning managementRodenticide Poisoning + Rat Killer paste poisoning management
Rodenticide Poisoning + Rat Killer paste poisoning managementVasif Mayan
 
Heparin Induced Thrombocytopeia (HIT)
Heparin Induced Thrombocytopeia (HIT)Heparin Induced Thrombocytopeia (HIT)
Heparin Induced Thrombocytopeia (HIT)Dr.Sayeedur Rumi
 
Ventilatory management of Acute Hypercapnic Respiratory Failure
Ventilatory management of Acute Hypercapnic Respiratory FailureVentilatory management of Acute Hypercapnic Respiratory Failure
Ventilatory management of Acute Hypercapnic Respiratory FailureVitrag Shah
 
epidural anesthesia
epidural anesthesiaepidural anesthesia
epidural anesthesiaShibinath VM
 
Management of Diabetic Autonomic Neuropathy
Management of Diabetic Autonomic Neuropathy Management of Diabetic Autonomic Neuropathy
Management of Diabetic Autonomic Neuropathy Shinjan Patra
 
Sodium bicarbonate therapy for patients with severe metabolic
Sodium bicarbonate therapy for patients with severe metabolicSodium bicarbonate therapy for patients with severe metabolic
Sodium bicarbonate therapy for patients with severe metabolicDr Ritesh kumar banode
 
Status asthmaticus by Pushpa Raj Sharma
Status asthmaticus by   Pushpa Raj SharmaStatus asthmaticus by   Pushpa Raj Sharma
Status asthmaticus by Pushpa Raj SharmaPushpa Sharma
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoningDhananjay Gupta
 
ASRA Guidelines 4th Edition
ASRA Guidelines 4th EditionASRA Guidelines 4th Edition
ASRA Guidelines 4th EditionDr Krunal Bhatt
 

Tendances (20)

Celphos poisoning
Celphos poisoningCelphos poisoning
Celphos poisoning
 
Cor pulmonale
Cor pulmonaleCor pulmonale
Cor pulmonale
 
Resp failure talk 9 10 bipap and hfnc emphasis
Resp failure talk 9 10  bipap and hfnc emphasisResp failure talk 9 10  bipap and hfnc emphasis
Resp failure talk 9 10 bipap and hfnc emphasis
 
100 most popular anesthesiologists of india 2018
100 most  popular anesthesiologists of india 2018100 most  popular anesthesiologists of india 2018
100 most popular anesthesiologists of india 2018
 
Rodenticide Poisoning + Rat Killer paste poisoning management
Rodenticide Poisoning + Rat Killer paste poisoning managementRodenticide Poisoning + Rat Killer paste poisoning management
Rodenticide Poisoning + Rat Killer paste poisoning management
 
Heparin Induced Thrombocytopeia (HIT)
Heparin Induced Thrombocytopeia (HIT)Heparin Induced Thrombocytopeia (HIT)
Heparin Induced Thrombocytopeia (HIT)
 
Ventilatory management of Acute Hypercapnic Respiratory Failure
Ventilatory management of Acute Hypercapnic Respiratory FailureVentilatory management of Acute Hypercapnic Respiratory Failure
Ventilatory management of Acute Hypercapnic Respiratory Failure
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
 
Sodium bicarbonate in acidosis
Sodium bicarbonate in acidosisSodium bicarbonate in acidosis
Sodium bicarbonate in acidosis
 
epidural anesthesia
epidural anesthesiaepidural anesthesia
epidural anesthesia
 
Management of Diabetic Autonomic Neuropathy
Management of Diabetic Autonomic Neuropathy Management of Diabetic Autonomic Neuropathy
Management of Diabetic Autonomic Neuropathy
 
Sodium bicarbonate therapy for patients with severe metabolic
Sodium bicarbonate therapy for patients with severe metabolicSodium bicarbonate therapy for patients with severe metabolic
Sodium bicarbonate therapy for patients with severe metabolic
 
Status asthmaticus by Pushpa Raj Sharma
Status asthmaticus by   Pushpa Raj SharmaStatus asthmaticus by   Pushpa Raj Sharma
Status asthmaticus by Pushpa Raj Sharma
 
Rapid sequence intubation
Rapid sequence intubationRapid sequence intubation
Rapid sequence intubation
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoning
 
Oxygen Therapy
Oxygen TherapyOxygen Therapy
Oxygen Therapy
 
Supervasmol
SupervasmolSupervasmol
Supervasmol
 
Acute pulmonary thromboembolism
Acute pulmonary thromboembolismAcute pulmonary thromboembolism
Acute pulmonary thromboembolism
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
 
ASRA Guidelines 4th Edition
ASRA Guidelines 4th EditionASRA Guidelines 4th Edition
ASRA Guidelines 4th Edition
 

Similaire à PARAQUAT POISONING: MANAGEMENT CHALLENGES

Paraquat toxicity explained.pptx
Paraquat toxicity explained.pptxParaquat toxicity explained.pptx
Paraquat toxicity explained.pptxMOPHCHOLAVANAHALLY
 
Oxygen toxicity and it’s mechanism
Oxygen toxicity and it’s mechanismOxygen toxicity and it’s mechanism
Oxygen toxicity and it’s mechanismrashree-singh
 
Organophosphorus poisoning presentation for postgraduate medicine level
Organophosphorus poisoning presentation for postgraduate medicine levelOrganophosphorus poisoning presentation for postgraduate medicine level
Organophosphorus poisoning presentation for postgraduate medicine levelNausheen57
 
PARAQUAT POISONING.pptx
PARAQUAT POISONING.pptxPARAQUAT POISONING.pptx
PARAQUAT POISONING.pptxSUNILBIHARI
 
3)ARDS -MANAGEMENT.pptx
3)ARDS -MANAGEMENT.pptx3)ARDS -MANAGEMENT.pptx
3)ARDS -MANAGEMENT.pptxRaj Kumar
 
Acute Respiratory Distress Syndrome
Acute Respiratory Distress SyndromeAcute Respiratory Distress Syndrome
Acute Respiratory Distress SyndromeRikin Hasnani
 
Poisoning plus MCQs 2012.
Poisoning plus MCQs 2012.Poisoning plus MCQs 2012.
Poisoning plus MCQs 2012.Shaikhani.
 
medicine.Poisoningintroduction.(dr.muhamad shaikhane)
medicine.Poisoningintroduction.(dr.muhamad shaikhane)medicine.Poisoningintroduction.(dr.muhamad shaikhane)
medicine.Poisoningintroduction.(dr.muhamad shaikhane)student
 
Anaesthesic Considerations in COPD.pptx
Anaesthesic Considerations in COPD.pptxAnaesthesic Considerations in COPD.pptx
Anaesthesic Considerations in COPD.pptxsanikashukla2
 
Chronic Obstructive Pulmonary Disease (Copd)
Chronic Obstructive Pulmonary Disease (Copd)Chronic Obstructive Pulmonary Disease (Copd)
Chronic Obstructive Pulmonary Disease (Copd)Nida Fatima
 
Hyperbaric oxygen therapy
Hyperbaric oxygen therapyHyperbaric oxygen therapy
Hyperbaric oxygen therapyYasha Gupta
 
Pulmonary aspiration.pptx
Pulmonary aspiration.pptxPulmonary aspiration.pptx
Pulmonary aspiration.pptxWaktolaGalata
 
seminar.pptx
seminar.pptxseminar.pptx
seminar.pptxNatanA7
 
Asthma management and treatment options.ppt
Asthma management and treatment options.pptAsthma management and treatment options.ppt
Asthma management and treatment options.pptmisgana18
 
Poisoning introduction plus MCQs2012.
Poisoning introduction  plus MCQs2012.Poisoning introduction  plus MCQs2012.
Poisoning introduction plus MCQs2012.Shaikhani.
 
Hyperbaric oxygen therapy
Hyperbaric oxygen therapyHyperbaric oxygen therapy
Hyperbaric oxygen therapyDeepak Kumar
 

Similaire à PARAQUAT POISONING: MANAGEMENT CHALLENGES (20)

Paraquat toxicity explained.pptx
Paraquat toxicity explained.pptxParaquat toxicity explained.pptx
Paraquat toxicity explained.pptx
 
Oxygen toxicity and it’s mechanism
Oxygen toxicity and it’s mechanismOxygen toxicity and it’s mechanism
Oxygen toxicity and it’s mechanism
 
Organophosphorus poisoning presentation for postgraduate medicine level
Organophosphorus poisoning presentation for postgraduate medicine levelOrganophosphorus poisoning presentation for postgraduate medicine level
Organophosphorus poisoning presentation for postgraduate medicine level
 
PARAQUAT POISONING.pptx
PARAQUAT POISONING.pptxPARAQUAT POISONING.pptx
PARAQUAT POISONING.pptx
 
COPD.pptx
COPD.pptxCOPD.pptx
COPD.pptx
 
Unit_6_COPD_1_.ppt
Unit_6_COPD_1_.pptUnit_6_COPD_1_.ppt
Unit_6_COPD_1_.ppt
 
3)ARDS -MANAGEMENT.pptx
3)ARDS -MANAGEMENT.pptx3)ARDS -MANAGEMENT.pptx
3)ARDS -MANAGEMENT.pptx
 
Acute Respiratory Distress Syndrome
Acute Respiratory Distress SyndromeAcute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome
 
Poisoning plus MCQs 2012.
Poisoning plus MCQs 2012.Poisoning plus MCQs 2012.
Poisoning plus MCQs 2012.
 
medicine.Poisoningintroduction.(dr.muhamad shaikhane)
medicine.Poisoningintroduction.(dr.muhamad shaikhane)medicine.Poisoningintroduction.(dr.muhamad shaikhane)
medicine.Poisoningintroduction.(dr.muhamad shaikhane)
 
Anaesthesic Considerations in COPD.pptx
Anaesthesic Considerations in COPD.pptxAnaesthesic Considerations in COPD.pptx
Anaesthesic Considerations in COPD.pptx
 
Chronic Obstructive Pulmonary Disease (Copd)
Chronic Obstructive Pulmonary Disease (Copd)Chronic Obstructive Pulmonary Disease (Copd)
Chronic Obstructive Pulmonary Disease (Copd)
 
Hyperbaric oxygen therapy
Hyperbaric oxygen therapyHyperbaric oxygen therapy
Hyperbaric oxygen therapy
 
Pulmonary aspiration.pptx
Pulmonary aspiration.pptxPulmonary aspiration.pptx
Pulmonary aspiration.pptx
 
OXYGEN AS A DRUG.pptx
OXYGEN AS A DRUG.pptxOXYGEN AS A DRUG.pptx
OXYGEN AS A DRUG.pptx
 
seminar.pptx
seminar.pptxseminar.pptx
seminar.pptx
 
Asthma management and treatment options.ppt
Asthma management and treatment options.pptAsthma management and treatment options.ppt
Asthma management and treatment options.ppt
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoning
 
Poisoning introduction plus MCQs2012.
Poisoning introduction  plus MCQs2012.Poisoning introduction  plus MCQs2012.
Poisoning introduction plus MCQs2012.
 
Hyperbaric oxygen therapy
Hyperbaric oxygen therapyHyperbaric oxygen therapy
Hyperbaric oxygen therapy
 

Plus de Dr Bodhisatwa Choudhuri

Plus de Dr Bodhisatwa Choudhuri (6)

Role of Tofacitinib in Rheumatoid Arthritis
Role of Tofacitinib in Rheumatoid ArthritisRole of Tofacitinib in Rheumatoid Arthritis
Role of Tofacitinib in Rheumatoid Arthritis
 
Hypertensive Emergencies
Hypertensive EmergenciesHypertensive Emergencies
Hypertensive Emergencies
 
Pediatric Respiratory & Cardiac Diseases.pptx
Pediatric Respiratory & Cardiac Diseases.pptxPediatric Respiratory & Cardiac Diseases.pptx
Pediatric Respiratory & Cardiac Diseases.pptx
 
Balanced Fluid Therapy - Dr B Choudhuri.pptx
Balanced Fluid Therapy - Dr B Choudhuri.pptxBalanced Fluid Therapy - Dr B Choudhuri.pptx
Balanced Fluid Therapy - Dr B Choudhuri.pptx
 
COVID-19 by Dr Bodhisatwa Choudhuri
COVID-19 by Dr Bodhisatwa ChoudhuriCOVID-19 by Dr Bodhisatwa Choudhuri
COVID-19 by Dr Bodhisatwa Choudhuri
 
Central Venous Access
Central Venous AccessCentral Venous Access
Central Venous Access
 

Dernier

History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfMyThaoAiDoan
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingSakthi Kathiravan
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxAbhishek943418
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 

Dernier (20)

History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursing
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 

PARAQUAT POISONING: MANAGEMENT CHALLENGES

  • 1. PARAQUAT POISONING DR BODHISATWA CHOUDHURI MBBS, MD(Med), MRCEM(UK), MEM(GWU-USA), MRCP Acute Medicine(UK), Dip Rheumatology(UK), FCCS, CCEBDM, Dip Echo(IAE) Consultant & In-Charge, Emergency & Critical Care, Medicine & Rheumatology, Parkview Super-specialty Hospital, Saltlake, Kolkata Secretary, SEMI West Bengal Chapter
  • 2. INTRODUCTION • Paraquat is a highly toxic & widely used bipiridyl compound • Was discovered in 1950s and found its way into agricultural use by 1962 • Primarily used for weed and grass control, but due to its highly poisonous nature was soon categorized as a “restricted-use” herbicide • However, as it is cheap and effective, its unregulated use in developing countries like India has made it a commonly used pesticide • It is exceedingly toxic to humans, and a minimal ingestion of 10–20 mL of 20% paraquat (around a mouthful) is lethal • Concentrated solutions are known to corrode even mild steel and aluminum
  • 3. INCIDENCE • Global problem • Trinidad, Tobago, Samoa – reported around 63-76% suicidal deaths on late nineties – due to Paraquat self-poisoning • England & Wales – reported 56% deaths due to paraquat use out of all pesticide ingestion between 1945-1989 • USA – Paraquat was responsible or greater number of deaths than any other pesticide in 2008 • The case fatality rate in paraquat is as high as 70% • Almost all European countries have banned paraquat due to high mortality
  • 4. PATHOPHYSIOLOGY • Oxidative stress and Generation of free radicals: • Redox cycling - Generates Reactive oxygen species (ROS) like – NADPH, NADH- Ubiquinone oxidoreductase, cytochrome P450 reductase, NO synthase, xanthine oxidase • Further generates superoxide (O2 -) inside cell • NO combines with superoxide to produce Peroxynitrite (ONOO-), a very strong oxidant • This strongly active oxygen & nitrite species is highly toxic majority of organs • Effects of Oxidative stress: • Lipid peroxidation • Mitochondrial toxicity • Oxidation of NADPH • Activation of NF-kB • Apoptosis
  • 5. MECHANISM OF TOXICITY • Multiple synergistic mechanisms – usually occurs simultaneously • The principal target organ for paraquat poisoning is the lung and kidney • Lungs: Major impact – alveolar epithelium remains the most affected part in lungs • Acute alveolitis, diffuse alveolar collapse, congested vessels, apoptosis, attachment of PMLs & activated platelets to vascular endothelium • 3 overlapping phases: acute destructive phase, proliferative phase, lung fibrosis • Kidney: Paraquat is actively secreted by the kidney – its accumulation in the proximal tubular epithelial cells at higher concentrations – causes vacuolation in the cells of the PCT – causing renal tubular necrosis • Liver: Hepatocellular injury occurs secondary to mitochondrial damage and endoplasmic reticulum degranulation
  • 6. TOXICOKINETICS • Rapid but incomplete absorption in gut upon ingestion • Rapidly distributed to highly vascular organs – lung, liver, kidney, muscle • Within 12-24 hours, kidneys excrete majority of the absorbed paraquat rapidly • But in severe poisoning, renal clearance declines rapidly after few hours – leads to slow clearance of paraquat distributed to deeper compartments – over days to weeks • Type II pneumocytes take up paraquat against concentration gradient – behaves like a third ‘toxic effect’ compartment – has even slower elimination rate than other deeper compartments
  • 7. CLINICAL PRESENTATION • Pulmonary: • Paraquat concentration in the lung is 10–20 times greater than in the plasma due to the energy-dependent uptake of the poison by the alveoli, which persists despite decreasing paraquat levels in the blood • Involvement of the lung in the form of diffuse alveolitis (over 1–3 days) and subsequent pulmonary fibrosis is the hallmark of paraquat poisoning • Symptoms – cough, hemoptysis, dyspnoea • Rarely, pneumothorax, pleural effusion and pulmonary edema • ARDS sets in after 24–48 hours of exposure • Skin: Erythema, eruptions, ulceration of skin may occur • Eyes: inflammation, ulceration of conjunctive, cornea, diminution of vision – healing is slow with complete recovery
  • 8. CLINICAL PRESENTATION • GI Tract: • Local irritation – nausea, vomiting • Caustic – Ulceration of tongue & mouth [Paraquat tongue], sloughing of oropharyngeal mucosa, dysphagia • Severe – perforation of esophagus, mediastinitis, surgical emphysema, pneumothorax, pleural effusion • Jaundice, hepatomegaly, hepatitis, pancreatitis – pain abdomen • Renal: • Oliguric or non-oliguric failure – mostly due to ATN – becomes evident in 1-2 days • Hematuria, proteinuria, glycosuria, excessive leakage of Na & urate
  • 9. PARAQUAT TONGUE Multiple erosions and superficial ulcers over tongue covered with yellowish necrotic debris
  • 10. CLINICAL PRESENTATION • CVS: • Initially sinus tachycardia • Lately, Myocarditis, VT, non-specific ST-T changes, intraventriclar conduction defects • Terminal – hypotension, sinus bradycardia • Neurological: cerebral edema – ataxia, convulsion, facial paresis, finally coma • Endocrine: adrenal cortical necrosis
  • 12. DIAGNOSIS & INVESTIGATIONS • Mainstay is circumstantial history - history of exposure, evidence of paraquat exposure and the amount of poison ingested • ABG – respiratory/metabolic acidosis • Routine labs: deranged based on organ involvement – regular monitoring of KFT, LFT, Electrolytes, Lactate, CBC • Serum Cr: Rate of increase correlates with survival – <0.034mg/dl/hr over 5 hours – survival; >0.049mg/dl/hr over 6 hours – death • Chest X-ray: useful in detecting early insult to the lungs (alveolitis), pulmonary fibrosis, ARDS, and rarer complications like pneumomediastinum or pneumothorax • ECG • Amylase, Lipase – to rule out toxin-induced pancreatitis
  • 13. SPECIFIC INVESTIGATIONS • Plasma and urine sodium dithionate tests - simple, bedside methods to assess systemic paraquat toxicity • In an alkaline medium, dithionate reduces paraquat to a blue radical (if urine paraquat concentration >1 mg/L or plasma paraquat concentration >2 mg/L) • Darker the colour, more the concentration • Helps in predicting prognosis in paraquat poisoning – positive test ~40% mortality, negative test ~100% survival • Qualitative assessment of paraquat poisoning • Measurement of Paraquat concentration in plasma and urine - quantitative assessment of paraquat poisoning, but not commonly available and the results are often delayed
  • 14. SEVERITY INDEX OF PARAQUAT POISONING (SIPP SCORE) • Best predictor of survival after self-poisoning • SIPP Score: The time from paraquat ingestion (to intensive treatment) [in hours] x Serum paraquat levels at admission [mg/dl] • Score <10 – survival is likely • Useful in planning treatment, determining the prognosis and studying the pathology of acute paraquat poisoning • Also effective in comparing therapeutic results at different stages of treatment and in evaluating new therapeutic methods • Challenges: imprecise time of exposure, paraquat assay within relevant time frame
  • 15. MANAGEMENT • There is no accepted & effective treatment guideline for paraquat poisoning • Most of the treatment options are extrapolated from small, uncontrolled animal studies • Treatment given is either supportive care alone or combinations of various supportive measures • Even the best centers have an overall mortality greater than 50%
  • 16.
  • 17. AIRWAY MANAGEMENT AND DECONTAMINATION • Patient is conscious with no vomiting - consider gastric lavage with activated charcoal (1–2 g/kg) or Fuller’s earth (1–2 g/kg) - aids in gastric decontamination and prevents further absorption • Supplemental oxygen is not advocated - as the oxygen free radical-mediated cytotoxic injury causes rapid worsening of pulmonary alveolar infiltrates, leading to the ARDS and subsequent pulmonary fibrosis if the patient survives the acute phase • Corrosive poison - so early insertion of a nasogastric tube - to maintain nutrition; may be very challenging due to severe ulcerations and friable mucosa, which may lead to complications including perforation • Keep NPM in the early phase • Oral lesions can be very painful - may need anticholinergic agents such as diphenhydramine; an anesthetic, such as viscous lidocaine; and an antacid or mucosal coating agent, such as magnesium or aluminum hydroxide, kaolin, or sucralfate • Antibiotics may be used for supervening infections
  • 18. VENTILATION • Development of type 2 respiratory failure may be an early predictor of ARDS in patients - worse outcome • Management of oxygenation and ventilation is identical to ARDS due to any other etiology (ARDS protocol, lung protective strategy) • Limit FiO2 to minimum to maintain PaO2 of about 60–65 mm Hg or SpO2 88–90% • Usually patients who get intubated for respiratory failure have a stormy course and deteriorate rapidly in few hours to days • Experimental: addition of NO (25 ppm) to inhaled gas
  • 19. HAEMODIALYSIS AND HAEMOFILTRATION • Initial management includes rehydration with IV fluids • Target UOP 1-2 ml/kg body wt/hr • In all cases of paraquat poisoning (significant ingestion), hemoperfusion is the first and the earliest modality of treatment of removal of paraquat • Clinical benefit only when initiated within 2 hours post-ingestion • Initiating HD/HP 2-4 hours after ingestion can reduce plasma paraquat concentration, but those taken up by lungs gets reduced negligibly, thus unlikely to change overall outcome
  • 20. • Proposed a treatment strategy - • to use up to seven hemoperfusion sessions (6–8 hours duration) • to be started within 4 hours of ingestion • maintained until plasma paraquat levels would be <0.2 mg/L
  • 21. • Prospective, controlled interventional study over 4 years • Recruited patients admitted to Shanghai Tenth People's Hospital within 48 hours after paraquat ingestion • Concluded that treatment with combined continuous venovenous hemofiltration and hemoperfusion significantly improved 90-day survival rates in paraquat poisoning
  • 22. IMMUNOSUPPRESSANTS • Interferes with the acute inflammatory response causing alveolitis and lung fibrosis • Options: Cyclophosphamide, Methylprednisolone pulse, Dexamethasone • Dexamethasone has shown to cause significantly reduced paraquat accumulation in lung tissues • No mode of treatment is shown to be effective in preventing lung injury or fibrosis once it is established • But some degree of benefit is seen when given early in course of treatment
  • 23. • Target: severe paraquat-poisoned patients with >50% to <90% predictive mortality • Initial pulse therapy with methylprednisolone (1 g/day for 3 days) and cyclophosphamide (15 mg/kg/day for 2 days), followed by dexamethasone 20 mg/day until Pao2 was >11.5 kPa (80 mm Hg) • Repeated pulse therapy with methylprednisolone (1 g/day for 3 days) and cyclophosphamide (15 mg/kg/day for 1 day), if Pao2 was <8.64 kPa (60 mm Hg) • The mortality rate (85.7%) of the control group was higher than that of the study group (31.3%; p = .0272)
  • 24. ANTIOXIDANTS • Tried to overcome circulatory shock due to reactive oxygen species, causing lactic acidosis, lung & renal injury • N-Acetyl cysteine: found to increase the level of glutathione (antioxidant) by suppressing the superoxide production - 150 mg/kg over 3 hours; 300 mg/kg over 24 hours for up to 3 weeks • Vitamin C: can donate electrons to free radicals and hence neutralize them • High doses of vitamin C (300 mg twice daily orally) reduced mortality in a case series of 10 patients • Vitamin E: acts by membrane stabilization, oxygen free radical scavenging, inhibiting activation of NF-kB • Deferoxamine: chelate iron that acts as a catalyst in the production of hydroxyl radicals (100 mg/kg over 24 hours) • Salicylic Acid: Anti-inflammatory, anti-oxidant, hydroxyl radical scavenger, inhibits activation of NF-kB & lipid peroxidation
  • 25. NOVEL THERAPIES • Edaravone: free radical-scavenging antioxidant, which also has antiapoptotic, necrotic, and anti-inflammatory effects – beneficial for protecting the kidneys and liver from paraquat poisoning, but did not reduce pulmonary fibrosis , only delayed it • Anti-C5a Antibodies: anti-inflammatory • Lung irradiation: proposed for inhibiting fibroblastic proliferation • Lung transplantation • ECMO: as a bridge to sequential bilateral lung transplantation
  • 26. CONCLUSION • Paraquat poisoning is a leading cause of death from pesticide poisoning with mortality of >70% • The literature on paraquat poisoning in India is sparse and the evidence on management is vague and lacks proven survival benefit • Though India is among the highest users of this herbicide worldwide, we are yet to equip ourselves with evidence-based treatment to successfully manage paraquat poisoning • Lungs are affected the most – as they take up the poison against a concentration gradient • No proven treatment or antidote • Oxygen supplementation may further worsen oxidative stress, so should be avoided in mild to moderate hypoxia • Extracorporeal elimination by HD/HP should be considered early – within 1-2 hours post- ingestion
  • 27. NATIONAL POISONS INFORMATION CENTRE (NPIC) Call 24 hours a day, 7 days a week, 365 days a year. Toll Free No. - 1800 116 117 Tel No.- 26589391 , 26593677
  • 29. THANK YOU Any questions?? Contact: 9830636315 E-mail: bodhi.doc@gmail.com